BRCA1 and ductal breast carcinoma in situ: They found only 1 case of lobular carcinoma in situ [LCIS (0.7%)] and no cases of ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC), even among BRCA1/2MUT carriers.